Search

(R2) Repositioning of Biosimilars: How Can the U.S. Optimize Biosimilar Utilization to Improve Patient Health and Lower Total Cost of Care

R2) Repositioning of Biosimilars: How Can the U.S. OptimizeBiosimilar Utilization to Improve Patient …
(D6) Mind the Gap: Bridging Pharmacy and Medical Benefits to Optimize Biosimilar Value

Medical Benefits to Optimize Biosimilar Value … Medical Benefits to Optimize Biosimilar Value …
APFM Section 2 Module 5: Special Considerations and Hot Topics

accelerated approval pathways, biosimilars, digital therapeutics, and …
Tuesday, 10/27 - Sessions from 1:45-2:45pm

0.00 (R2) Repositioning of Biosimilars: How Can the U.S. OptimizeBiosimilar Utilization to Improve Patient …
Innovations in Lipid Management: Integrating Emerging and Pipeline Therapies

drug loss of exclusivity and biosimilar launches. Prior to working …
Advanced Principles of Formulary Management

accelerated approval pathways, biosimilars, digital therapeutics, and … considerations for incorporating biosimilars, digital therapeutics, and …

You are here